ArticleCancers2020

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.

Noemí Puig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.